Home News

Kiadis Pharma announces result of Annual General Meeting

Amsterdam, The Netherlands, June 28, 2016 – Kiadis Pharma N.V. (“Kiadis Pharma” or the “Company”) (Euronext Amsterdam and Brussels: KDS), a clinical stage biopharmaceutical company developing innovative T-cell immunotherapy treatments […]

28 June 2016

Read more